HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The inflammatory modulation effect of glutamine-enriched total parenteral nutrition in postoperative gastrointestinal cancer patients.

Abstract
The objective of this study is to explore the inflammatory modulation effect of glutamine-enriched total parenteral nutrition (TPN) by investigating the alterations of inflammation-related cytokines in gastrointestinal (GI) cancer patients postoperatively. Fifty GI cancer patients received postoperative 7 days of isocaloric and isonitrogenous TPN after operation. They were randomly divided to receive either glutamine-enriched TPN or standard TPN. The inflammation-related cytokines including interleukin-6, interleukin-10, and tumor necrosis factor-α were also determined. Records of nutritional assessments, inflammatory status, and postoperative complications were compared between the two groups. Of 50 enrolled patients, 25 patients were classified as the intervention group, and the control group also comprised 25 patients. The differences of gender, age, primary GI malignancies, and hematological and biochemical data between the two compared groups were not statistically significant (all P > 0.05). Compared with standard TPN, a higher serum prealbumin level and better nitrogen balance were observed in glutamine-enriched TPN (P = 0.039 and 0.048 respectively). A significantly lower serum interleukin-6 level was found in comparing glutamine-enriched with standard TPN (P = 0.01), but not in interleukin-10 (P = 0.374) and tumor necrosis factor-α levels (P = 0.653). Moreover, a significant lower serum C-reactive protein level was detected in glutamine-enriched TPN compared with standard TPN (P = 0.013). Indeed, four cases of postoperative infectious complications were noted in the control group, but no postoperative infectious complications were observed in the interventional group (P = 0.037). Our present study shows that glutamine-enriched TPN may be beneficial in improving the inflammatory status and decreasing the infectious morbidity in postoperative GI cancer patients.
AuthorsChien-Yu Lu, Ying-Ling Shih, Li-Chu Sun, Jui-Fen Chuang, Cheng-Jen Ma, Fang-Ming Chen, Deng-Chyang Wu, Jan-Sing Hsieh, Jaw-Yuan Wang
JournalThe American surgeon (Am Surg) Vol. 77 Issue 1 Pg. 59-64 (Jan 2011) ISSN: 1555-9823 [Electronic] United States
PMID21396307 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Inflammation Mediators
  • Glutamine
  • Interleukin-10
  • C-Reactive Protein
Topics
  • Aged
  • C-Reactive Protein (analysis)
  • Cytokines (analysis)
  • Digestive System Surgical Procedures (methods)
  • Double-Blind Method
  • Female
  • Gastrointestinal Neoplasms (complications, pathology, surgery)
  • Glutamine (administration & dosage)
  • Humans
  • Inflammation (prevention & control)
  • Inflammation Mediators (analysis)
  • Interleukin-10 (analysis)
  • Male
  • Malnutrition (etiology, therapy)
  • Middle Aged
  • Nutritional Status
  • Parenteral Nutrition, Total (methods)
  • Postoperative Care (methods)
  • Quality of Life
  • Reference Values
  • Treatment Outcome
  • Weight Gain

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: